Ampyra

Rick on April 11th, 2010

Ampyra [am-PEER-ah], the brand name for a new drug named fampridine-SR, has been approved by the US Food and Drug Administration for the treatment of Multiple Sclerosis. The new drug is the first Multiple Sclerosis drug to enhance some neurological functioning for MS patients. Dr. Andrew Goodman, chief of the University of Rochester Medical Center’s […]

Continue reading about Ampyra, A New Multiple Sclerosis Drug with Promise

css.php